Biomarkers in diabetic neuropathy

References

• Agarwal, N., et al. 2020. SUMOylation of enzymes and ion channels in sensory neurons protects against metabolic dysfunction, neuropathy, and sensory loss in diabetes. Neuron, 107 (6), 1141–1159.
   PubMed Web of Science ®Google Scholar
• Angst, D.B.M., et al. 2020. Cytokine levels in neural pain in leprosy. Frontiers in immunology, 11, 23.
   PubMed Web of Science ®Google Scholar
• Ayton, S., et al. 2013. Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease. Annals of neurology, 73 (4), 554–559.
   PubMed Web of Science ®Google Scholar
• Barutta, F., et al. 2018. MicroRNA and microvascular complications of diabetes. International journal of endocrinology, 2018, 1–20.
   Web of Science ®Google Scholar
• Bheereddy, P., et al. 2020. SIRT1 activation by polydatin alleviates oxidative damage and elevates mitochondrial biogenesis in experimental diabetic neuropathy. Cellular and molecular neurobiology. Advance online publication.
   PubMed Web of Science ®Google Scholar
• Bodman, M. A. and Varacallo, M. (2018) Diabetic neuropathy [online]. Treasure Island FL: StatPearls. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28723038 [Accessed 4 December 2018].
   Google Scholar
• Bogacka, J., et al. 2020. Blockade of CCR4 diminishes hypersensitivity and enhances opioid analgesia - evidence from a mouse model of diabetic neuropathy. Neuroscience, 441, 77–92.
   PubMed Web of Science ®Google Scholar
• Bonhof, G.J., et al. 2019. Emerging biomarkers, tools, and treatments for diabetic polyneuropathy. Endocrine reviews, 40 (1), 153–192.
   PubMed Web of Science ®Google Scholar
• Boulton, A., Gries, F., and Jervell, J., 1998. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabetic medicine, 15 (6), 508–514.
   PubMed Web of Science ®Google Scholar
• Boulton, A.J.M., et al. 2005. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes care, 28 (4), 956–962.
   PubMed Web of Science ®Google Scholar
• Brownlee, M., 2001. Biochemistry and molecular cell biology of diabetic complications. Nature, 414 (6865), 813–820.
   PubMed Web of Science ®Google Scholar
• Carr, M.W., et al. 1994. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proceedings of the National Academy of Sciences of the United States of America, 91 (9), 3652–3656.
   PubMed Web of Science ®Google Scholar
• Cha, J.J., et al. 2018. Long-term study of the association of adipokines and glucose variability with diabetic complications. The Korean journal of internal medicine, 33 (2), 367–382.
   PubMed Web of Science ®Google Scholar
• Chandrasekharan, B. and Srinivasan, S., 2007. Diabetes and the enteric nervous system. Neurogastroenterology and Motility, 19 (12), 951–960.
   PubMed Web of Science ®Google Scholar
• Chandrasekaran, K., et al. 2019. Overexpression of Sirtuin 1 protein in neurons prevents and reverses experimental diabetic neuropathy. Brain: a journal of neurology, 142 (12), 3737–3752.
   PubMedGoogle Scholar
• Chatterjee, P., et al. 2019. Effect of deep tissue laser therapy treatment on peripheral neuropathic pain in older adults with type 2 diabetes: a pilot randomized clinical trial. BMC Geriatrics, 19 (1), 218.
   PubMed Web of Science ®Google Scholar
• Chen, J. and Li, Q., 2020. Lipoic acid decreases the expression of poly ADP-ribose polymerase and inhibits apoptosis in diabetic rats. Diabetes, metabolic syndrome and obesity: targets and therapy, 13, 1725–1731.
   PubMed Web of Science ®Google Scholar
• Chen, J., et al. 2019. miRNA-155 silencing reduces sciatic nerve injury in diabetic peripheral neuropathy. Journal of molecular endocrinology, 63 (3), 227–238.
   PubMed Web of Science ®Google Scholar
• Choi, A.M. and Alam, J., 1996. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. American journal of respiratory cell and molecular biology, 15 (1), 9–19.
   PubMed Web of Science ®Google Scholar
• Cohen, K., et al. 2015. Pharmacological treatment of diabetic peripheral neuropathy. P&T, 40 (6), 372–388.
   PubMedGoogle Scholar
• Dantzer, F., et al. 1998. Functional association of poly(ADP-ribose) polymerase with DNA polymerase alpha-primase complex: a link between DNA strand break detection and DNA replication. Nucleic acids research, 26 (8), 1891–1898.
   PubMed Web of Science ®Google Scholar
• Dewanjee, S., et al. 2018. Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets. European journal of pharmacology, 833, 472–523.
   PubMed Web of Science ®Google Scholar
• Dorcely, B., et al. 2017. Diabetes, metabolic syndrome and obesity: targets and therapy dovepress novel biomarkers for prediabetes, diabetes, and associated complications. Diabetes, metabolic syndrome and obesity: targets and therapy, 10, 345–361.
   PubMedGoogle Scholar
• Duffy, A. M., Bouchier-Hayes, D. J. and Harmey, J. H. (2013) ‘Vascular Endothelial Growth Factor (VEGF) and Its Role in Non-Endothelial Cells: Autocrine Signalling by VEGF’. Landes Bioscience. Available at: https://www.ncbi.nlm.nih.gov/books/NBK6482/ (Accessed: 29 June 2018).
   Google Scholar
• Dull, M.M., et al. 2019. Methylglyoxal causes pain and hyperalgesia in human through C-fiber activation. Pain, 160 (11), 2497–2507.
   PubMed Web of Science ®Google Scholar
• England, J.D., et al. 2005. Distal symmetric polyneuropathy: a definition for clinical research - Report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology, 64 (2), 199–207.
   PubMed Web of Science ®Google Scholar
• Fajrin, F.A., et al. 2020. Ginger extract and its compound, 6-shogaol, attenuates painful diabetic neuropathy in mice via reducing TRPV1 and NMDAR2B expressions in the spinal cord. Journal of ethnopharmacology, 249, 112396.
   PubMed Web of Science ®Google Scholar
• Farhi, L.E., Plewes, J.L., and Olszowka, A.J., 1976. Lung carbonate dehydratase (carbonic anhydrase), CO2 stores and CO2 transport. Ciba Foundation symposium, 38, 235–249.
   Google Scholar
• Feldman-Billard, S., et al. 2018. Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes. Diabetes & metabolism, 44 (1), 4–14.
   PubMed Web of Science ®Google Scholar
• Freeman, R., 2005. Autonomic peripheral neuropathy. The lancet, 365 (9466), 1259–1270.
   PubMed Web of Science ®Google Scholar
• Fu, Z., et al. 2017. Malat1 activates autophagy and promotes cell proliferation by sponging miR-101 and upregulating STMN1, RAB5A and ATG4D expression in glioma. Biochemical and biophysical research communications, 492 (3), 480–486.
   PubMed Web of Science ®Google Scholar
• Gao, Y.-J., et al. 2009. JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. The journal of neuroscience, 29 (13), 4096–4108.
   PubMed Web of Science ®Google Scholar
• Gonçalves, N.P., et al. 2017. Schwann cell interactions with axons and microvessels in diabetic neuropathy. Nature reviews. Neurology, 13 (3), 135–147.
   PubMed Web of Science ®Google Scholar
• Grisold, A., Callaghan, B.C., and Feldman, E.L., 2017. Mediators of diabetic neuropathy: is hyperglycemia the only culprit? Current opinion in endocrinology, diabetes, and obesity, 24 (2), 103–111.
   PubMedGoogle Scholar
• Gugliucci, A., 2017. Formation of fructose-mediated advanced glycation end products and their roles in metabolic and inflammatory diseases. Advances in nutrition, 8 (1), 54–62.
   PubMed Web of Science ®Google Scholar
• Gupte, A.A., Lyon, C.J., and Hsueh, W.A., 2013. Nuclear factor (erythroid-derived 2)-like-2 factor (Nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and nonalcoholic steatohepatitis. Current diabetes reports, 13 (3), 362–371.
   PubMed Web of Science ®Google Scholar
• Hellman, N.E. and Gitlin, J.D., 2002. Ceruloplasmin metabolism and function. Annual review of nutrition, 22 (1), 439–458.
   PubMedGoogle Scholar
• Hoda, K., et al. 2013. Iron metabolism and related disorders. In: D. Rimoin, R. Pyeritz, and B. Korf, eds. Emery and Rimoin’s principles and practice of medical genetics. Amsterdam, The Netherlands: Elsevier, 1–41.
   Google Scholar
• Hong, S., et al. 2008. The TRPV1 receptor is associated with preferential stress in large dorsal root ganglion neurons in early diabetic sensory neuropathy. Journal of neurochemistry, 105 (4), 1212–1222.
   PubMed Web of Science ®Google Scholar
• Huang, Y., Chan, P., and Halliday, G., 2007. Genetics of Parkinson’s disease. In: G.A. Qureshi, ed. Oxidative stress and neurodegenerative disorders. Amsterdam, The Netherlands: Elsevier, 663–697.
   Google Scholar
• Impellizzeri, D., et al. 2019. The neuroprotective effects of micronized PEA (PEA-m) formulation on diabetic peripheral neuropathy in mice. FASEB Journal, 33 (10), 11364–11380.
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation. 2019. IDF diabetes atlas. 9th ed. Brussels, Belgium: IDF.
   Google Scholar
• Jha, J.C., et al. 2014. NAD(P)H oxidase isoforms as therapeutic targets for diabetic complications. Expert review of endocrinology & metabolism, 9 (2), 111–122.
   PubMedGoogle Scholar
• Jia, G.L., et al. 2020. Cav-1 participates in the development of diabetic neuropathy pain through the TLR4 signaling pathway. Journal of cellular physiology, 235 (3), 2060–2070.
   PubMed Web of Science ®Google Scholar
• Juster-Switlyk, K. and Smith, A.G., 2016. Updates in diabetic peripheral neuropathy. F1000Research, 5, 738.
   Google Scholar
• Kallinikou, D., et al. 2019. Diabetic neuropathy in children and adolescents with type 1 diabetes mellitus: diagnosis, pathogenesis, and associated genetic markers. Diabetes/metabolism research and reviews, 35 (7), e3178.
   PubMed Web of Science ®Google Scholar
• Laddha, A.P. and Kulkarni, Y.A., 2019. VEGF and FGF-2: promising targets for the treatment of respiratory disorders. Respiratory medicine, 156, 33–46.
   PubMed Web of Science ®Google Scholar
• Laddha, A.P. and Kulkarni, Y.A., 2020. NADPH oxidase: a membrane-bound enzyme and its inhibitors in diabetic complications. European journal of pharmacology, 881, 173206.
   PubMed Web of Science ®Google Scholar
• Lawrence, T., 2009. The nuclear factor NF-kappaB pathway in inflammation. Cold spring harbor perspectives in biology, 1 (6), a001651.
   PubMed Web of Science ®Google Scholar
• Leng, J., et al. 2020. Neuroprotective effect of diosgenin in a mouse model of diabetic peripheral neuropathy involves the nrf2/ho-1 pathway. BMC complementary medicine and therapies, 20 (1), 126.
   PubMedGoogle Scholar
• Li, J., et al. 2019. Therapeutic effects of moxibustion simultaneously targeting Nrf2 and NF-κB in diabetic peripheral neuropathy. Applied biochemistry and biotechnology, 189 (4), 1167–1182.
   PubMed Web of Science ®Google Scholar
• Li, R.J., et al. 2020. Ketogenic diets and protective mechanisms in epilepsy, metabolic disorders, cancer, neuronal loss, and muscle and nerve degeneration. Journal of food biochemistry, 44 (3), e13140.
   PubMed Web of Science ®Google Scholar
• Lim, Y.-C., et al. 2014. Prevention of VEGF-mediated microvascular permeability by C-peptide in diabetic mice. Cardiovascular research, 101 (1), 155–164.
   PubMed Web of Science ®Google Scholar
• Lin, C.J., et al. 2019. Expression of miR-217 and HIF-1α/VEGF pathway in patients with diabetic foot ulcer and its effect on angiogenesis of diabetic foot ulcer rats. Journal of endocrinological investigation, 42 (11), 1307–1317.
   PubMed Web of Science ®Google Scholar
• Liu, G. and Daneshgari, F., 2014. Diabetic bladder dysfunction. Chinese medical journal, 127 (7), 1357–1364.
   PubMed Web of Science ®Google Scholar
• Liu, T., et al. 2017. NF-κB signaling in inflammation. Signal transduction and targeted therapy, 2 (1), 17023.
   PubMed Web of Science ®Google Scholar
• Liu, W., et al. 2020. Effects of hirudin on high glucose-induced oxidative stress and inflammatory pathway in rat dorsal root ganglion neurons. Chinese journal of integrative medicine, 26 (3), 197–204.
   PubMed Web of Science ®Google Scholar
• Liu, Y., et al. 2020. Schwann cells apoptosis is induced by high glucose in diabetic peripheral neuropathy. Life sciences, 248, 117459.
   PubMed Web of Science ®Google Scholar
• Long, J., et al. 2019. Effect of shock wave on vascular lesions in diabetic rats - PubMed. Pain physician, 5, 505–510.
   Google Scholar
• Lotti, M. and Bleecker, M.L., 2015. Principles and practice of occupational neurology. In: P. Vinken and G. Bruyn, eds. Handbook of clinical neurology. Amsterdam, The Netherlands: Elsevier, 3–8.
   Google Scholar
• Ma, X.-Y., et al. 2015. Malat1 as an evolutionarily conserved lncRNA, plays a positive role in regulating proliferation and maintaining undifferentiated status of early-stage hematopoietic cells. BMC genomics, BioMed Central, 16 (1), 676.
   PubMedGoogle Scholar
• Malik, R.A., et al. 2011. Small fibre neuropathy: role in the diagnosis of diabetic sensorimotor polyneuropathy. Diabetes/metabolism research and reviews, 27 (7), 678–684.
   PubMed Web of Science ®Google Scholar
• Matheson, A., et al. 2010. Urinary biomarkers involved in type 2 diabetes: a review. Diabetes/Metabolism Research and Reviews, 26 (3), 150–171.
   PubMed Web of Science ®Google Scholar
• Mert, T., et al. 2020. Effects of immune cell-targeted treatments result from the suppression of neuronal oxidative stress and inflammation in experimental diabetic rats. Naunyn-Schmiedeberg’s archives of pharmacology, 393 (7), 1293–1302.
   PubMed Web of Science ®Google Scholar
• Mizukami, H. and Yagihashi, S., 2010. [Cytokine role in diabetic neuropathy]. Nihon Rinsho. Japanese journal of clinical medicine, 68 (9), 563–567.
   PubMedGoogle Scholar
• Nargis, T. and Chakrabarti, P., 2018. Significance of circulatory DPP4 activity in metabolic diseases. IUBMB life, 70 (2), 112–119.
   PubMed Web of Science ®Google Scholar
• Negi, G., et al. 2015. Heme oxygenase-1, a novel target for the treatment of diabetic complications: focus on diabetic peripheral neuropathy. Pharmacological research, 102, 158–167.
   PubMed Web of Science ®Google Scholar
• Obrosova, I.G., et al. 2004. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes, 53 (3), 711–720.
   PubMed Web of Science ®Google Scholar
• Oghbaei, H., et al. 2020. Sodium nitrate preconditioning prevents progression of the neuropathic pain in streptozotocin-induced diabetes Wistar rats. Journal of diabetes and metabolic disorders, 19 (1), 105–113.
   PubMed Web of Science ®Google Scholar
• Okdahl, T., et al. 2020. Increased levels of inflammatory factors are associated with severity of polyneuropathy in type 1 diabetes. Clinical endocrinology, 93 (4), 419–428.
   PubMed Web of Science ®Google Scholar
• Ostan, R., et al. 2015. Inflammaging and cancer: a challenge for the Mediterranean diet. Nutrients, 7 (4), 2589–2621.
   PubMed Web of Science ®Google Scholar
• Oza, M.J. and Kulkarni, Y.A., 2020. Formononetin ameliorates diabetic neuropathy by increasing expression of SIRT1 and NGF. Chemistry and biodiversity, 17 (6), e2000162.
   PubMed Web of Science ®Google Scholar
• Paisley, P. and Serpell, M., 2017. Improving pain control in diabetic neuropathy. The practitioner, 261 (1802), 23–26.
   PubMedGoogle Scholar
• Papanas, N., Vinik, A.I., and Ziegler, D., 2011. Neuropathy in prediabetes: does the clock start ticking early? Nature reviews. Endocrinology, 7 (11), 682–690.
   PubMed Web of Science ®Google Scholar
• Pascariu, M., Bendayan, M., and Ghitescu, L., 2004. Correlated endothelial caveolin overexpression and increased transcytosis in experimental diabetes. The journal of histochemistry and cytochemistry 52 (1), 65–76.
   PubMed Web of Science ®Google Scholar
• Petropoulos, I.N., et al. 2018. Diagnosing diabetic neuropathy: something old, something new. Diabetes & metabolism journal, 42 (4), 255–269.
   PubMed Web of Science ®Google Scholar
• Pop-Busui, R., 2010. Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes care, 33 (2), 434–441.
   PubMed Web of Science ®Google Scholar
• Puthanveetil, P., et al. 2015. Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells. Journal of cellular and molecular medicine, 19 (6), 1418–1425.
   PubMed Web of Science ®Google Scholar
• Sanada, M., Matsui, M., and Yasuda, H., 2016. Pathogenesis of diabetic neuropathy. Nihon Rinsho. Japanese journal of clinical medicine, 74 (2), 223–228.
   PubMedGoogle Scholar
• Savic-Radojevic, A., et al. 2017. Novel biomarkers of heart failure. Advances in clinical chemistry, 79, 93–152.
   PubMed Web of Science ®Google Scholar
• Schamarek, I., et al. 2016. Adiponectin, markers of subclinical inflammation and nerve conduction in individuals with recently diagnosed type 1 and type 2 diabetes. European journal of endocrinology, 174 (4), 433–443.
   PubMed Web of Science ®Google Scholar
• Selvarajah, D., et al. 2019. Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. The lancet. Diabetes & endocrinology, 7 (12), 938–948.
   PubMed Web of Science ®Google Scholar
• Shaqura, M., et al. 2014. New insights into mechanisms of opioid inhibitory effects on capsaicin-induced TRPV1 activity during painful diabetic neuropathy. Neuropharmacology, 85, 142–150.
   PubMed Web of Science ®Google Scholar
• Sharopov, B.R., et al. 2018. TRPV1 alterations in urinary bladder dysfunction in a rat model of STZ-induced diabetes. Life sciences, 193, 207–213.
   PubMed Web of Science ®Google Scholar
• Shrivastava, U., et al. 2017. Obesity, diabetes and cardiovascular diseases in India: public health challenges. Current diabetes reviews, 13 (1), 65–80.
   PubMed Web of Science ®Google Scholar
• Simeoli, R. and Fierabracci, A., 2019. Insights into the role of MicroRNAs in the onset and development of diabetic neuropathy. International journal of molecular sciences, 20 (18), 4627.
   PubMed Web of Science ®Google Scholar
• Sloan, G., et al. 2018. A new look at painful diabetic neuropathy. Diabetes research and clinical practice, 144, 177–191.
   PubMed Web of Science ®Google Scholar
• Smith, A.G. and Singleton, J.R., 2013. Obesity and hyperlipidemia are risk factors for early diabetic neuropathy. Journal of diabetes and its complications, 27 (5), 436–442.
   PubMed Web of Science ®Google Scholar
• Smith, G.D., et al. 2002. TRPV3 is a temperature-sensitive vanilloid receptor-like protein. Nature, 418 (6894), 186–190.
   PubMed Web of Science ®Google Scholar
• Spallone, V., et al. 2011. Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy⋆. Nutrition, metabolism, and cardiovascular diseases, 21 (1), 69–78.
   PubMed Web of Science ®Google Scholar
• Stino, A.M. and Smith, A.G., 2017. Peripheral neuropathy in prediabetes and the metabolic syndrome. Journal of diabetes investigation, 8 (5), 646–655.
   PubMed Web of Science ®Google Scholar
• Sugimoto, K., et al. 2019. Cutaneous microangiopathy in patients with type 2 diabetes: impaired vascular endothelial growth factor expression and its correlation with neuropathy, retinopathy and nephropathy. Journal of diabetes investigation, 10 (5), 1318–1331.
   PubMed Web of Science ®Google Scholar
• Surendran, S., et al. 2020. Effect of resveratrol on dipeptidyl peptidase-4 inhibitors pharmacokinetics: an in vitro and in vivo approach. Chemico-biological interactions, 315, 108909.
   PubMed Web of Science ®Google Scholar
• Suryavanshi, S.V. and Kulkarni, Y.A., 2017. NF-κβ: a potential target in the management of vascular complications of diabetes. Frontiers in pharmacology, 8, 798.
   PubMed Web of Science ®Google Scholar
• Tajti, J., et al. 2016. Alleviation of pain in painful diabetic neuropathy. Expert opinion on drug metabolism & toxicology, 12 (7), 753–764.
   PubMed Web of Science ®Google Scholar
• Tavakkoly-Bazzaz, J., et al. 2010. VEGF gene polymorphism association with diabetic neuropathy. Molecular biology reports, 37 (7), 3625–3630.
   PubMed Web of Science ®Google Scholar
• Tesfaye, S. and Selvarajah, D., 2012. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes/metabolism research and reviews, 28, 8–14.
   PubMed Web of Science ®Google Scholar
• Tomlinson, D.R., Willars, G.B., and Carrington, A.L., 1992. Aldose reductase inhibitors and diabetic complications. Pharmacology & therapeutics, 54 (2), 151–194.
   PubMed Web of Science ®Google Scholar
• Tschritter, O., et al. 2003. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes, 52 (2), 239–243.
   PubMed Web of Science ®Google Scholar
• Urner, S., et al. 2020. NADPH oxidase inhibition: preclinical and clinical studies in diabetic complications. Antioxidants & redox signaling, 33 (6), 415–434.
   PubMed Web of Science ®Google Scholar
• Samokyszyn VM, et al. (1989) Inhibition of superoxide and ferritin-dependent lipid peroxidation by ceruloplasmin. Journal of biological chemistry, 264 (1), 21–26.
   PubMed Web of Science ®Google Scholar
• Várkonyi, T., et al. 2017. Advances in the management of diabetic neuropathy. Minerva medica, 108 (5), 419–437.
   PubMed Web of Science ®Google Scholar
• Veves, A. and King, G.L., 2001. Can VEGF reverse diabetic neuropathy in human subjects? The journal of clinical investigation, 107 (10), 1215–1218.
   PubMed Web of Science ®Google Scholar
• Vincent, A.M., et al. 2004. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocrine reviews, 25 (4), 612–628.
   PubMed Web of Science ®Google Scholar
• Vincent, A.M., et al. 2011. Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nature reviews. neurology, 7 (10), 573–583.
   PubMed Web of Science ®Google Scholar
• Vinik, A.I., et al. 2013. Diabetic neuropathy. Endocrinology and metabolism clinics of North America, 42 (4), 747–787.
   PubMed Web of Science ®Google Scholar
• Wang, W., Hao, Y., and Li, F., 2019. Notoginsenoside R1 alleviates high glucose-evoked damage in RSC96 cells through down-regulation of miR-503. Artificial cells, nanomedicine, and biotechnology, 47 (1), 3947–3954.
   PubMed Web of Science ®Google Scholar
• Williams, K.A., et al. 2008. Neuropathic pain syndromes. In: H. Benzon, C.L. Wu, and J.P. Rathmell, eds. Raj’s practical management of pain. Amsterdam, The Netherlands: Elsevier, 427–443.
   Google Scholar
• Williams, T.M. and Lisanti, M.P., 2004. The caveolin proteins. Genome biology, 5 (3), 214.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2019. World report on vision. Geneva, Switzerland: WHO.
   Google Scholar
• Xourgia, E., Papazafiropoulou, A., and Melidonis, A., 2018. Circulating microRNAs as biomarkers for diabetic neuropathy: a novel approach. World Journal of Experimental Medicine, 8 (3), 18–23.
   PubMedGoogle Scholar
• Yang, X., et al. 2019. Effect and mechanism of the Bruton tyrosine kinase (BTK) inhibitor ibrutinib on rat model of diabetic foot ulcers. Medical science monitor, 25, 7951–7957.
   PubMed Web of Science ®Google Scholar
• Yerra, V.G., Kalvala, A.K., and Kumar, A., 2017. Isoliquiritigenin reduces oxidative damage and alleviates mitochondrial impairment by SIRT1 activation in experimental diabetic neuropathy. The journal of nutritional biochemistry, 47, 41–52.
   PubMed Web of Science ®Google Scholar
• Yu, Z.-W., et al. 2012. Role of nuclear factor (erythroid-derived 2)-like 2 in metabolic homeostasis and insulin action: a novel opportunity for diabetes treatment? World journal of diabetes, 3 (1), 19–28.
   PubMedGoogle Scholar
• Zakin, E., Abrams, R., and Simpson, D.M., 2019. Diabetic neuropathy. Seminars in neurology, 39 (5), 560–569.
   PubMed Web of Science ®Google Scholar
• Zhang, B.Y., et al. 2020. Alpha-lipoic acid downregulates TRPV1 receptor via NF-κB and attenuates neuropathic pain in rats with diabetes. CNS neuroscience & therapeutics, 26 (7), 762–772.
   PubMed Web of Science ®Google Scholar
• Zhang, N., et al. 2019. Effect of ropivacaine on peripheral neuropathy in streptozocin diabetes-induced rats through TRPV1-CGRP pathway. Bioscience reports, 39 (11), BSR20190817.
   PubMedGoogle Scholar
• Zhang, X., Hamblin, M.H., and Yin, K.-J., 2017. The long noncoding RNA Malat1: its physiological and pathophysiological functions. RNA biology, 14 (12), 1705–1714.
   PubMed Web of Science ®Google Scholar
• Zhou, L., et al. 2018. Long non-coding RNA MALAT1 interacts with transcription factor Foxo1 to regulate SIRT1 transcription in high glucose-induced HK-2 cells injury. Biochemical and biophysical research communications, 503 (2), 849–855.
   PubMed Web of Science ®Google Scholar